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A subset of cerebrovascular 
pericytes originates from mature 
macrophages in the very early 
phase of vascular development in 
CNS
Seiji Yamamoto1, Masashi Muramatsu2, Erika Azuma1,3, Masashi Ikutani4, Yoshinori Nagai4,22, 
Hiroshi Sagara5, Bon-Nyeo Koo6,7, Satomi Kita8, Erin O’Donnell7, Tsuyoshi Osawa9, Hiroyuki 
Takahashi10, Ken-ichi Takano11, Mitsuko Dohmoto12, Michiya Sugimori13, Isao Usui14, 
Yasuhide Watanabe15, Noboru Hatakeyama16, Takahiro Iwamoto8, Issei Komuro17, Kiyoshi 
Takatsu4,18, Kazuyuki Tobe14, Shumpei Niida19, Naoyuki Matsuda20, Masabumi Shibuya21 & 
Masakiyo Sasahara1
Pericytes are believed to originate from either mesenchymal or neural crest cells. It has recently 
been reported that pericytes play important roles in the central nervous system (CNS) by regulating 
blood-brain barrier homeostasis and blood flow at the capillary level. However, the origin of CNS 
microvascular pericytes and the mechanism of their recruitment remain unknown. Here, we show a 
new source of cerebrovascular pericytes during neurogenesis. In the CNS of embryonic day 10.5 mouse 
embryos, CD31+F4/80+ hematopoietic lineage cells were observed in the avascular region around the 
dorsal midline of the developing midbrain. These cells expressed additional macrophage markers such 
as CD206 and CD11b. Moreover, the CD31+F4/80+ cells phagocytosed apoptotic cells as functionally 
matured macrophages, adhered to the newly formed subventricular vascular plexus, and then divided 
into daughter cells. Eventually, these CD31+F4/80+ cells transdifferentiated into NG2/PDGFRβ/desmin-
expressing cerebrovascular pericytes, enwrapping and associating with vascular endothelial cells. 
These data indicate that a subset of cerebrovascular pericytes derive from mature macrophages in 
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the very early phase of CNS vascular development, which in turn are recruited from sites of embryonic 
hematopoiesis such as the yolk sac by way of blood flow.
It is largely accepted that cerebrovascular pericytes enwrap cerebral blood vessels through their foot processes1–3. 
In addition, it was recently reported that pericytes play an important role in the regulation of blood flow in the 
brain at the capillary level4, 5. Pericytes are also important for blood-brain barrier (BBB) stability6–8. Insufficient 
cerebrovascular pericyte recruitment has been reported in mice lacking platelet-derived growth factor-B 
(PDGF-B) or platelet-derived growth factor receptor beta (PDGFRβ)9, 10. Such deficiencies lead to endothelial 
hyperplasia, impaired endothelial differentiation, increased vascular leakage, and the formation of rupturing 
microaneurysms. Mice carrying mutated PDGF-B or with conditionally regulated endothelium-specific PDGF-B 
expression have a hypomorphic pericyte phenotype. These mice show increased water content in their brains 
resulting from BBB perturbations such as excess endothelial transcytosis and altered astrocyte end-foot polar-
ization6. In the embryonic phase, pericytes also play a critical role in BBB function. More than a week before 
astrocyte generation, pericyte-endothelial cell interactions are crucial for the regulation of BBB formation, and 
disruption of these interactions leads to BBB dysfunction7. In a previous report, we clearly demonstrated that 
the pericyte recruitment disorder in a mouse with postnatally-induced systemic depletion of PDGFRβ shows 
BBB disruption and severe vascular leakage after stroke induced by photothrombotic middle cerebral artery 
occlusion11.
Several lines of experimental evidence have suggested that macrophage subsets contribute to vascular 
development in both physiological and pathological conditions. In the developing mouse brain, macrophages 
act as cellular chaperones for vascular anastomosis12. These macrophages share molecular similarities with 
the pro-angiogenic tissue macrophages that are important for vascular development. In the developing retina, 
myeloid cells control retinal vascular density13. These cells contribute to normal development of the retinal vas-
culature depending on the non-canonical Wnt-Flt1 pathway. In pathological conditions, macrophage subsets 
contribute to atheroma development in atherosclerosis, which is a major cause of death worldwide14. In other 
conditions, such as transplantation, macrophage subsets appear to transdifferentiate into lymphatic endothe-
lial cells for incorporation into the lymphatic vessels15, 16. In a mouse corneal transplant model, macrophages 
express lymphatic vessel markers and contribute to inflammation-dependent corneal lymphangiogenesis15. In 
renal transplantation, recipient-derived circulating macrophages may be incorporated into the lymphatic system 
of the transplanted organ16.
Previously, it was thought that pericytes were derived from the mesenchymal cells that resided in the connec-
tive tissues surrounding blood vessels or from neural crest cells17–22. However, little is known about the origin 
of cerebrovascular pericytes and the mechanism underlying their recruitment to cerebral blood vessels. Here, 
we show a novel source of cerebrovascular pericytes in the very early phase of CNS vascular development. We 
describe CD31+F4/80+ cells that primarily function as phagocytes and express several macrophage markers. 
These cells are observed to adhere to the newly formed subventricular vascular plexus (SVP), divide into daugh-
ter cells, and eventually transdifferentiate into NG2/PDGFRβ/desmin-expressing cerebrovascular pericytes. 
Therefore, in the very early phase of CNS vascular development, we conclude that a subset of cerebrovascular 
pericytes is recruited by blood flow from sites of embryonic hematopoiesis, such as the yolk sac, and derive from 
the CD31+F4/80+ cells, a subset of mature macrophages.
Results
A subset of mature macrophages associates with cerebral blood vessels and expresses peri-
cyte markers. During neurogenesis in mice, considerable formation of the perineural vascular plexus (PNP) 
and subventricular vascular plexus (SVP) occurs from embryonic day 9.5 (E9.5) to E12.5, as shown by previous 
study23 (Supplementary Figure 1a). We precisely observed the newly-formed SVP front using confocal micros-
copy at E10.5 (Figure 1a, Supplementary Figure 1b and c). At this time point, cells positive for CD31 and negative 
for collagen type IV, a well-known blood vessel-specific extracellular matrix component, surrounded the SVP 
front (Figure 1a, arrowheads). These CD31+ cells were large, had various morphologies, and were sometimes 
found adhered to the capillaries at the vascular front (Figure 1a, arrowheads). High magnification images showed 
that these CD31+ cells adhered to brain microcapillaries, implying that CD31+ cells may differentiate into cere-
brovascular pericytes (Figure 1b, arrowhead).
Because the CD31+ cells that infiltrated the avascular area of the dorsal midline were relatively large and 
had varied morphologies (Figure 1a, Supplementary Figure 2a–c), we examined whether these cells expressed 
macrophage markers. Multi-color immunofluorescence analysis revealed that these CD31+ cells expressed F4/80 
(Figure 1c), a marker of mature macrophages in mice24. The CD31+F4/80+ cells also expressed other macrophage 
markers such as CD206 and CD11b, suggesting that CD31+F4/80+ cells were functionally differentiated mac-
rophages (Supplementary Figure 3). Terminally differentiated mature macrophages can engulf apoptotic cells25, 26. 
Transmission electron microscopy showed that the CD31+F4/80+ cells at the dorsal midline could phagocytose 
apoptotic cells with their pseudopodia (Figure 1d). In addition, cleaved caspase 3-positive apoptotic cells were 
phagocytosed by the F4/80+ phagocytic cells located in the dorsal midline area which were corresponding to the 
CD31+F4/80+ cells based on the distinct tissue localization and unique phagocyte-like morphology in the dorsal 
midline of the midbrain (Figure 1d, right).
Several lines of experimental evidence have demonstrated the possibility of macrophage transdifferentia-
tion15, 16. We next examined whether the CD31+F4/80+ cells expressed a pericyte marker. Whole mount immu-
nostaining of the brain at E10.5 showed that the CD31+ cells located at the dorsal midline, corresponding to 
the CD31+F4/80+ cells, expressed both NG2 (Figure 1e), a well-accepted early pericyte marker1, 27, and the 
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Figure 1. CD31+F4/80+ cells have a mature macrophage phenotype and express a pericyte marker. (a) 
CD31+ cells infiltrate the developing subventricular vascular plexus (SVP) vascular front (red, arrowheads). 
Collagen type IV marks the blood vessels (green). (b) High magnification image of an adhered CD31+ cell (red, 
arrowhead). (c) CD31+ cells in the dorsal midline express F4/80 (green). The merged image with stained nuclei 
(blue) shows the mature phagocytic macrophage morphology. (d) Representative image of CD31+F4/80+-
equivalent phagocytes as observed by TEM. The highest magnification image is shown in the middle. Red 
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pan-leukocyte marker CD45 (Figure 1f, arrowheads). These results suggest that CD31+F4/80+ cells may transdif-
ferentiate from hematopoietic cell-derived mature macrophages into cerebrovascular pericytes.
CD31+F4/80+ cells transdifferentiate into cerebrovascular pericytes. To determine whether 
CD31+F4/80+ cells transdifferentiate into pericytes in an in vivo model, we performed a Matrigel plug assay. 
CD31+F4/80+ cells that were fractionated from Egfp Tg28 embryos by flow cytometry (Supplementary Figure 4) 
were subcutaneously administered in Matrigel to a wild type (WT) mouse. Two weeks later, the immunostained 
Matrigel sections showed that EGFP+ cells, which were the fractionated CD31+F4/80+ cells from the Egfp Tg 
mice, were tightly associated with the newly-formed host-derived capillaries (Figure 2a), and these cells also 
expressed the pericyte markers PDGFRβ (Figure 2b and c) and desmin (Figure 2d). The mature EGFP+ pericytes 
might not express CD31 or below the detection limit as determined by immunostaining.
We utilized another set of an experiment using an explant culture model to clarify whether CD31+F4/80+ cells 
transdifferentiate into pericytes. Fractionated EGFP+CD31+F4/80+ cells were injected into the cerebral ventricles 
of E10.5 WT mouse embryos. Two days later, immunostained brain specimens showed that the EGFP+ cells had 
adhered to the cerebral blood vessels and expressed the pericyte marker NG2 (Figure 2e). Statistical analysis 
indicated that more than 95% of the EGFP+ cells that adhered to the cerebral blood vessels transdifferentiated 
into NG2+ pericytes (Figure 2f). These data strongly suggest that CD31+F4/80+ cells possess the ability to trans-
differentiate into pericytes in various extracellular milieus both in vivo and ex vivo.
To obtain direct evidence of CD31+F4/80+ cells transdifferentiating into pericytes, we performed 
single-cell-tracing time-lapse analysis. This technique can provide direct evidence for transdifferentiation without 
losing any windows of time. CD31+F4/80+-equivalent EGFP reporter cells were isolated from the dorsal midline 
of the midbrain of E10.5 Egfp Tg mouse embryos, based on their distinct tissue localization and unique phagocyte 
morphology (Supplementary Figure 2). These cells were co-cultured with b.End5 cells, a mouse cerebrovascu-
lar endothelial cell-derived cell line (Figure 3a). The seeded EGFP reporter cells were able to adhere tightly to 
the b.End5 cells by their foot processes. During the single-cell-tracing time-lapse study, the EGFP reporter cell 
digested phagocytosed apoptotic cells (Supplementary Movie 1). Theoretically, terminally differentiated, mature, 
phagocytic macrophages do not actively proliferate under physiological conditions unless highly genetically engi-
neered29, 30. However, the EGFP reporter cell divided into 2 daughter cells (Figure 3b, Supplementary Movie 1). 
Immediately after the time-lapse study, the EGFP+ daughter cells were subjected to immunostaining with an 
anti-NG2 antibody, which clearly showed that the EGFP+ daughter cells expressed NG2 and thus confirmed 
that the EGFP reporter cells isolated from the dorsal midline area could transdifferentiate into cerebrovascular 
pericytes after digesting apoptotic cells and dividing (Figure 3c and d). In addition, the EGFP+ daughter cells still 
expressed NG2 and retained typical pericyte morphology 3 days later (Figure 3e).
To examine whether CD31+F4/80+ cells originate from hematopoietic cells, a fate-mapping study was per-
formed, which is a valid procedure for cell fate determination. We utilized R26R-Eyfp;Vav1-Cre mice, generated 
by crossing R26R-Eyfp and Vav1-Cre mice, which display hematopoietic cell-specific EYFP expression31, 32. In 
R26R-Eyfp;Vav1-Cre embryos, EYFP+ hematopoietic lineage cells were observed in the dorsal midline area at 
E10.5 and were found to co-express CD31 and NG2 (Figure 4a), indicating that these cells corresponded to the 
CD31+F4/80+ cells described earlier, based on their distinct tissue localization, marker expression, and unique 
phagocyte-like morphology. Moreover, many NG2+ cerebrovascular pericytes found elsewhere in the brain of 
R26R-Eyfp;Vav1-Cre embryos also expressed EYFP (Figure 4b, higher magnification in 4c).
Cerebrovascular pericyte coverage is delayed in Csf1op/op mouse. To investigate whether 
CD31+F4/80+ cells contribute to the pericyte coverage of the SVP, we utilized a Csf1op/op mouse33, 34, which is 
deficient in macrophages. Compared to WT littermates, significantly fewer CD31+ cells were recruited to the 
dorsal midline in E10.5 Csf1op/op embryos (Figure 5a and b). Moreover, in Csf1op/op embryos, no NG2+ cells or 
CD31+NG2+ cells (equivalent to the CD31+F4/80+ cells) were found at the dorsal midline (Figure 5c and d, and 
Supplementary Figure 5a). We next observed the NG2+ pericyte coverage of the SVP at E10.5. Compared to WT 
littermates, Csf1op/op embryos showed significantly decreased pericyte coverage on the lateral side of the SVP 
(Figure 5e and f). Moreover, on the dorsal side of the vascular front, there was also a significantly greater differ-
ence between Csf1op/op mice and their WT littermates (Figure 5e and g). There were no significant differences in 
the vascular density or branching of the SVP at E10.5 between the two genotypes (Supplementary Figure 5b–d). 
In contrast to E10.5, on E12.5, no clear difference in pericyte coverage was observed between Csf1op/op mice and 
their WT littermates (Supplementary Figure 6). These data suggest that the CD31+F4/80+ cells that infiltrate the 
dorsal midline by E10.5 contribute to pericyte coverage of the SVP during neurovascular development. In addi-
tion, there are at least 2 pericyte sources and/or recruitment routes at this stage, enabling compensation for the 
lack of CD31+F4/80+ cells in the Csf1op/op mouse.
To confirm whether the expression levels of pericyte-related genes are reduced in Csf1op/op mice, we performed 
a microarray analysis using mRNA extracted from the dorsal midline area of an E10.5 Csf1op/op mouse and WT 
littermate. The expression of macrophage-related genes and phagocytosis/engulfment-related genes (Gene 
Ontology terms) in the dorsal midline of the Csf1op/op mouse were 39% and 54% lower, respectively, than in the 
arrowheads indicate a pseudopod, a structure typical of mature phagocytic macrophages. a, apoptotic cells 
(green); p, phagocytosed apoptotic cells (blue); n, nucleus (orange). Right panel in (d), CD31+F4/80+ cells 
phagocytose apoptotic cells. (e) CD31+ cells (red) express the pericyte marker NG2 (green). Insets are high 
magnification images of the area inside the dotted squares. (f) CD31+ cells (red) co-express CD45 (cyan) and 
NG2 (green). Scale bars represent 100 μm (a and e); 10 μm (b, c, d left and right), and (f); and 1 μm (d, middle).
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Figure 2. Matrigel plug and explant culture assays on CD31+F4/80+ cells. (a) EGFP+CD31+F4/80+ cells 
were embedded into Matrigel followed by subcutaneous injection into mice. EGFP+ cells associate with newly 
formed blood vessels. Merge with DIC image shows the appearance of the Matrigel plug. (b) High magnification 
images of the boxed area in (a). EGFP+ cells express the pericyte marker PDGFRβ (cyan). (c) EGFP+ cells 
(green) express PDGFRβ (cyan), instead of CD31 (red) in the higher magnification image. (d) Cross-section of 
a capillary. The transplanted EGFP+ cell (green) enwraps the capillary and expresses the pericyte marker desmin 
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WT littermate (Figure 6a and b). It has been reported that cerebral pericytes can contract to regulate capillary 
blood flow4, 5. The Csf1op/op mouse embryo showed 50% lower expression of smooth muscle contraction-related 
genes compared to the expression levels in the WT littermate (Figure 6c). Moreover, lower expression of selected 
pericyte-related genes was observed in the Csf1op/op embryo compared to the WT littermate embryo (Figure 6d). 
The microarray data were supported by real-time PCR experiments. Compared to WT littermates, Csf1op/op mouse 
embryos showed lower expression of the top 4 down-regulated pericyte-related genes, Kcnj8, Rgs5, Dlk1, and 
Abcc9 (Figure 6e), suggesting that the pericyte deficiency may be caused by a macrophage deficiency. To confirm 
whether CD31+F4/80+ cells are involved in angiogenesis, we reassessed the microarray data. The expression of 
angiogenesis-related genes in the dorsal midline of the Csf1op/op mouse showed downregulation of some genes; 
however, the overall expression level of angiogenesis-related genes basically appeared similar to the WT littermate 
(Supplementary Figure 7). These data, in combination with the previously described observations on vascular 
density and branching (Supplementary Figure 5), suggest that CD31+F4/80+ cells may not primarily promote 
angiogenesis at E10.5.
To determine whether another major hematopoietic cell subgroup, lymphocytes, contributes to cer-
ebrovascular pericyte development during this time, we utilized the lymphoid-lineage-deficient Rag2−/− 
mouse35. Rag2 mRNA was found to be expressed in the major embryonic hematopoietic organs, such 
as the aorta-gonad-mesonephros (AGM) region and the yolk sac, at E10.5 (Supplementary Figure 8a). 
Immunofluorescence on Rag2−/− and WT littermate embryos revealed no difference in NG2+ cells (equiva-
lent to the CD31+F4/80+ cells, Supplementary Figure 8b and c). Furthermore, statistical analysis demonstrated 
that there were no significant differences in the numbers of NG2+, F4/80+, NG2+F4/80+, NG2+CD31+, or 
NG2+CD31+F4/80+ cells between Rag2−/− and WT mice (Supplementary Figure 8c). The only significant differ-
ence observed was in the number of CD31+ cells. These data strongly suggest that macrophages, but not lymphoid 
cells, contribute to pericyte development in the SVP.
CD31+F4/80+ cells are recruited from the yolk sac by blood flow and directly infiltrate the dor-
sal midline before potentially transdifferentiating into pericytes. To clarify the hematopoietic site 
of origin of the CD31+F4/80+ cells, we used an Ncx1−/− mouse36, 37, which has a non-beating heart. The lack 
of blood flow resulted in no hematopoietic cells in the dorsal aorta or the cutaneous microvasculature, par-
ticularly TER-119+ embryonic erythrocytes, a major blood cell type at E10.5 (Supplementary Figure 9a and b). 
In Ncx1−/− embryos, the lack of blood flow resulted in no NG2+ cells (equivalent to the CD31+F4/80+ cells) 
recruitment to the dorsal midline area at E10.5 (Figure 7a and Supplementary Figure 9c). In addition, no NG2+ 
pericytes were observed in the SVP of Ncx1−/− mouse embryos (Figure 7a). However, in contrast to other sites, 
yolk sac hematopoiesis was not substantially diminished in the mutant embryos (Figure 7a and Supplementary 
Figure 9d). These data strongly suggest that CD31+F4/80+ cells are recruited from an extraembryonic hemato-
poietic organ, the yolk sac. By a more direct method, CD31+F4/80+NG2− cells were fractionated from the yolk 
sacs of R26-mCherry embryos by flow cytometry (Supplementary Figure 9e) and co-cultured with b.End5 cells 
and neural stem/progenitor cells. Immunofluorescence data showed that mCherry+ cells, which derived from 
CD31+F4/80+NG2− cells, expressed NG2 at 7 days in vitro (DIV) (Figure 7b). Moreover, these mCherry+ cells 
were found to both express NG2 and enwrap blood vessels in a retinal explant model (Figure 7c). These results 
suggest that hematopoietic lineage cells isolated from the yolk sac transdifferentiated into functionally mature 
pericytes that associated with vascular endothelial cells both in vitro and ex vivo.
Finally, to determine whether CD31+F4/80+ cells directly infiltrate the dorsal midline area or are recruited 
via the developing SVP, we utilized an Nrp1−/− mouse38, which is deficient in SVP morphogenesis. In Nrp1−/− 
embryos, NG2+ cells (equivalent to the CD31+F4/80+ cells) presented in the dorsal midline area on E10.5 
(Figure 8a), suggesting that these cells might be transported through the conduit of the PNP by blood flow and 
then extravasate and infiltrate the neuroepithelium around the dorsal midline area. There was no significant dif-
ference in NG2+ cell infiltration between the Nrp1−/− and WT embryos (WT, 4.33 ± 0.67; Nrp1−/−, 5.18 ± 0.75). 
Our data clearly demonstrate that there are at least two mechanisms of pericyte recruitment to the cerebral blood 
vessels. The first mechanism, direct recruitment to the dorsal midline, was demonstrated in this study (Figures 8b 
and Supplementary Figure 10). Another mechanism is locomotion along the microvessels, which is a well-known 
developmental process in the field of vascular biology (Supplementary Figure 10) 22, 39–41.
Discussion
Our findings clearly demonstrate that a specific subset of CD31+F4/80+ macrophages infiltrate the dorsal midline 
at E10.5 and transdifferentiate into NG2/PDGFRβ/desmin-expressing cerebrovascular pericytes, which cover the 
SVP in the very early phase of CNS vascular development. These cells are recruited from the yolk sac, the most 
important extraembryonic hematopoietic organ in the early to middle embryonic stage. The CD31+F4/80+ cells, 
at first, phagocytosed apoptotic cells similarly to mature macrophages when they infiltrated the dorsal midline. 
Then, they began to proliferate. Theoretically, terminally differentiated, mature, phagocytic macrophages do not 
actively proliferate under physiological conditions29. Aziz and colleagues have reported that MafB/c-Maf-deficient 
mature macrophages can proliferate in vitro and in vivo without dedifferentiation and do not produce a tumor30. 
(red). Nucleus are counterstained with Hoechst (blue). (e) Explant culture assay of EGFP+CD31+F4/80+ cells. 
EGFP+CD31+F4/80+ cells were injected into age-matched WT embryos. EGFP+ cells adhere to a host cerebral 
blood vessel (arrowheads) and express NG2 (cyan, arrowheads). (f) EGFP+ cells that adhere to cerebral blood 
vessels express NG2 (****P < 0.0001; n = 3). Scale bars represent 100 μm (a and b), and 10 μm (c, d and e). All 
error bars indicate the mean ± s.e.m.
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Figure 3. Single-cell-tracing time-lapse analysis of CD31+F4/80+ cells. (a) The single-cell-tracing time-lapse 
clearly shows that the EGFP reporter cells (equivalent to the CD31+F4/80+ cells) undergo transdifferentiation 
into pericytes. EGFP reporter cells (green) were cultured with b.End5 cells (red). Initially, the EGFP 
reporter cells exhibited various morphologies when they were seeded onto b.End5 cells. Black spots indicate 
phagocytosed apoptotic cells. (b) During the single-cell-tracing time-lapse, the EGFP reporter cells proliferated 
into daughter cells (arrowheads). (c) Low magnification image of the single-cell-tracing time-lapse specimen, 
www.nature.com/scientificreports/
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However, MafB/c-Maf-deficient mature macrophages are highly genetically engineered cells and their study was 
not performed under physiological conditions. Our data clearly demonstrate that the CD31+F4/80+ cells iden-
tified here are a subset of mature macrophages with phagocytic activity that retain proliferative ability under 
physiological conditions at least in the very early phase of vascular development in the CNS. Our findings also 
suggest that the function of CD31+F4/80+ cells appears to be involved in vascular maturation as cerebrovascular 
pericytes rather than angiogenic macrophages42.
Several lines of experimental evidence have shown that macrophage subsets appear to contribute or transdif-
ferentiate into other cell types, especially lymphatic endothelial cells15, 16. In a mouse corneal transplant model, 
CD11b-positive macrophages contributed to inflammation-dependent corneal lymphangiogenesis as LYVE-1 or 
PROX-1-positive lymphatic vascular endothelium-like cells15. In addition, 30%–50% of CD11b-positive cells in 
peritoneal exudates express lymphatic endothelial cell markers such as LYVE-1, Podoplanin, or PROX-1 and give 
rise to vessel-like structures in vitro. In gender-mismatched renal transplantation, when the recipient rejects the 
transplant and has a high rate of overall lymphatic endothelial proliferation as well as massive chronic inflamma-
tion, recipient-derived circulating macrophages transdifferentiate into lymphatic endothelial cells in the trans-
planted tissue16. However, these findings were exclusively observed in highly pathological conditions. In contrast 
to these, for the first time, we demonstrate that a fully mature macrophage subset with phagocytic activity can 
transdifferentiate into cerebrovascular pericytes under physiological conditions.
Morphologically, pericytes have been identified in the embryonic rat brain, where they are located on the 
abluminal surface of the vasculature43. To date, it has been reported that pericytes may be a heterogeneous cellular 
group with various functions and origins1, 21, 22, 44, 45. In fact, multiple pericyte sources such as the mesenchyme 
and the neural crest have been previously reported17, 18, 21, 34, 46, 47. In an adult lineage-tracing study of mouse bone 
marrow transplantation, a bone marrow origin for mural cells during VEGF-A induced dermal angiogenesis was 
suggested48. However, to the best of our knowledge, we clearly demonstrate here, for the first time, that cerebro-
vascular pericytes are derived from hematopoietic organs such as the yolk sac under physiological conditions 
in the very early phase of vascular development in the CNS. Furthermore, hematopoietic stem/progenitor cells 
lining the stem cell niche of such an organ could be recruited by blood flow to the developing brain as a hemato-
poietic lineage pericyte subset via functionally mature macrophages. In the very early phase of CNS vascular 
development, although the contribution of this hematopoietic lineage pericyte subset in the CNS vasculature may 
be involved in vascular maturation, the precise function and the mutual complementation with other pericytes 
derived from different origins remains to be determined.
Some reports have demonstrated the importance of pericytes in microvascular homeostasis4–8, 49. Under physi-
ological conditions, pericytes play a pivotal role in blood flow regulation in cerebral and retinal microcapillaries4, 5. 
In addition, pericytes play a crucial role in the regulation of the BBB in adults6–8, 11. Conversely, pericyte loss is 
considered a hallmark of several diseases such as diabetic retinopathy, age-related macular degeneration, and 
cancer-associated retinopathy, and is correlated to the severity of the illness50–52. To date, many vascular regener-
ation studies have been performed53–55. However, very few have focused on pericyte recruitment to the regener-
ated blood vessels for accelerating blood vessel maturation. Our findings suggest that a subset of pericytes may 
be derived from hematopoietic stem/progenitor cells in pathological conditions as well. In the clinical field of 
vascular regenerative medicine, pericytes derived from hematopoietic lineage cells may induce the maturation of 
newly formed blood vessels to improve ischemic regions. In addition, hematopoietic lineage pericyte subset may 
be valuable in the treatment of unstable, leaky retinal blood vessels in patients with diabetes mellitus as part of a 
re-stabilization therapy56.
In rodent models of tumor transplantation, pericytes also play an important role in tumor development57. 
Recently, we reported that NG2-, PDGFRβ-, or αSMA-positive pericytes may be associated with tumor growth in 
mouse allograft and xenograft models57. However, although many NG2-, PDGFRβ-, or αSMA-positive pericytes 
are recruited to the tumor clump in WT mice, the number of pericytes and the tumor volume are significantly 
reduced in Flt-1 TK−/− mice, which display an impairment of macrophage function58. Others and we have sug-
gested that tumor pericytes contribute to tumor development and that pericyte-targeted therapy may inhibit 
tumor growth56, 57, 59. In this study, our findings suggest that anti-macrophage reagents could be used as an add-on 
therapeutic approach for patients with cancer at the preclinical and clinical levels, in addition to pericyte-targeted 
therapy.
Until now, the precise mechanism underlying the recruitment of pericytes to the cerebral microvasculature 
was not fully understood. Our study clearly demonstrates that there are at least 2 pericyte-recruiting mechanisms 
during cerebral blood vessel development (Supplementary Figure 10). One is “direct recruitment to the dorsal 
midline”, which was shown in this study. Another is “locomotion along the microvessels”, which is a well-accepted 
process in developmental biology22, 34, 39–41. We have tried to define the trigger for direct recruitment to the dorsal 
midline; however, our immunostaining and microarray-based studies exploring potential chemoattractant factors 
or integral receptors have not yet identified any candidates.
In conclusion, we have clearly demonstrated that the mature macrophages infiltrating the dorsal midline of the 
midbrain transdifferentiate into cerebrovascular pericytes in the very early phase of vascular development in the 
CNS. These results have defined the first wave of pericyte recruitment by identifying the cellular origin, thereby 
EGFP+ daughter cells (circles), and a movie frame (square). (d) EGFP+ daughter cells express the pericyte 
marker NG2 (magenta). (e) EGFP+ daughter cells still expressed NG2 (magenta) and retained typical pericyte 
morphology over 3 days. VE-cadherin staining indicates b.End5 cells (red). Nuclei are counterstained with 
Hoechst (blue). Arrowheads indicate foot processes. Scale bars represent 50 μm (a), 10 μm (b and d), 100 μm (c), 
and 20 μm (e).
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demonstrating that macrophage derived-pericytes are, at least in part, an actual component among the total 
cerebrovascular pericyte population at this stage. Although the contribution of this subset of pericytes in later 
developmental and postnatal stages remains to be determined in future study, this study opens a new avenue to 
the understanding of the origin and role of cerebrovascular pericytes. Our findings also suggest the possibility of 
macrophage-based mature/stable blood vessel regeneration therapy in the field of vascular regenerative medicine. 
In addition, these cells may be a new target for anti-angiogenic therapy in patients with cancer.
Methods
Animals. Descriptive analyses were performed on the following transgenic and knockout mouse lines: Csf1op/
op 33, 34, Rag2−/− 35, Ncx1−/− 37, Egfp transgenic (Egfp Tg) 28, Rosa26R26-mCherry/+ (R26-mCherry)60, Rosa26R26R-Eyfp/+ 
(R26R-Eyfp);Vav1-Cre31, 32, and Neuropilin1−/− (Nrp1−/−)38. All experimental animal procedures were approved 
by the Committee for Institutional Animal Care and Use at the University of Toyama (Toyama, Japan), and exper-
iments were carried out in accordance with the approved guidelines.
Immunofluorescence. Immunofluorescence was performed on whole tissues, frozen sections, and cultured 
cells as previously described61, 62. Briefly, whole mount specimens were fixed in 4% paraformaldehyde on ice 
for 1 hour. Tissue sections were fixed in 4% paraformaldehyde, immersed in 30% PBS buffered sucrose, and 
embedded in OCT compound (Sakura Finetek Japan, Tokyo, Japan). Frozen sections (30 μm) were cut on a 
CM3000 cryostat (Leica Microsystems, Wetzlar, Germany). Cells were fixed in 4% paraformaldehyde on ice for 
15 min. All specimens were permeabilized in a 0.3% Triton X-100/PBS solution and then incubated with pri-
mary antibodies diluted in 0.03% Triton X-100/PBS with 10% normal goat serum (VECTOR LABORATORIES, 
Burlingame, CA) overnight at 4 °C. The following primary antibodies were used for immunostaining: hamster 
anti-CD31 (1:200; Merck Millipore, Billerica, MA), rat anti-CD31 (1:100; BD Biosciences, San Jose, CA), rab-
bit anti-collagen type IV (1:500; Merck Millipore), rat anti-F4/80 (1:50; Bio-Rad Laboratories, Hercules, CA), 
rabbit anti-cleaved caspase 3 (1:200; Cell Signaling Technology, Danvers, MA), rabbit anti-NG2 (1:200; Merck 
Millipore), rat anti-CD45 (1:100; BD Biosciences), rabbit FITC-conjugated anti-GFP (1:500; Life Technologies 
Corporation, Carlsbad, CA), rat anti-CD105 (1:100; BD Biosciences), rat anti-CD140b (1:100; eBioscience, San 
Diego, CA), rabbit anti-desmin (1:500; Abcam, Cambridge, UK), rat anti-TER119 (1:100; eBioscience), mouse 
Cy3-conjugated anti-αSMA (1:500; Sigma-Aldrich, St. Louis, MO), rat anti-CD11b (1:20; BD Biosciences), rat 
Alexa647-conjugated anti-F4/80 (1:20; Bio-Rad Laboratories), and rat Alexa488-conjugated anti-CD206 (1:20; 
Figure 4. Fate mapping study of CD31+F4/80+ cells. A fate mapping study showed that CD31+F4/80+ cells 
originate from hematopoietic cells. (a) In E10.5 R26R-Eyfp;Vav1-Cre mouse embryos, CD31+ cells (red, 
equivalent to the CD31+F4/80+ cells), which infiltrate the dorsal midline and phagocytose apoptotic cells 
confirmed by multiple-nuclei (blue), express EYFP (green) and NG2 (magenta). (b) On the lateral side of the 
SVP (red), many NG2+ pericytes (magenta) express EYFP (green). (c) High magnification image of a typical 
pericyte expressing EYFP and NG2 (soma, asterisk; foot processes, arrowheads). Scale bars represent 10 μm (a 
and c) and 100 μm (b).
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Figure 5. Csf1op/op mice have very few CD31+F4/80+NG2+cells and sparse pericyte coverage. (a–d) Very few 
CD31+NG2+ cells are found in the dorsal midline area of E10.5 Csf1op/op mouse embryos. While CD31+ cells 
(equivalent to the CD31+F4/80+ cells) infiltrate the dorsal midline of WT littermates, very few are observed 
in Csf1op/op embryos (a). CD31+ (b), NG2+ (c), and CD31+NG2+ (d) cells in both genotypes (***P < 0.001; 
WT = 4; Csf1op/op = 3; 200 × 200 μm, see also Supplementary Figure 5a). (e–g) Loss of NG2+ cells causes sparse 
pericyte coverage of the SVP in the Csf1op/op mouse. Although intact NG2+ pericyte coverage is observed in WT 
littermates, sparse pericyte coverage is seen in Csf1op/op mice (e). NG2+ pericyte coverage of the lateral side area 
(f) and dorsal side area (g) is significantly decreased in Csf1op/op mice (*P < 0.05; **P < 0.01; WT = 8; Csf1op/
op = 7; 200 × 200 μm). Images for coverage analysis were rendered to the same depth (10 µm). Coverage rate 
was calculated as NG2 pixels/ CD31 pixels. Scale bars represent 100 μm (a and b). All error bars indicate the 
mean ± s.e.m.
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Bio-Rad Laboratories). The secondary antibodies (Ab or Fab) used were Alexa-Fluor350, Alexa-Fluor488, 
Alexa-Fluor568, or Alexa-Fluor633 conjugated (Life Technologies Corporation), or Cy3 or Cy5 conjugated 
(Jackson ImmunoResearch Laboratories, West Grove, PA), and used at dilutions of 1:250–1:500. Nuclei were 
stained with Hoechst 33258 (Nacalai Tesque, Koto, Japan) or TO-PRO-3 (Life Technologies Corporation). The 
imaging system used was a TCS SP5 confocal system (Leica Microsystems) and a BZ-9000 fluorescent microscope 
(KEYENCE, Osaka, Japan).
Figure 6. Macrophage deficiency results in down-regulation of pericyte-related genes in Csf1op/op mouse 
embryos. (a) Microarray data revealed 7 of 18 (39%) macrophage-related genes were down-regulated in the 
dorsal midline area of the Csf1op/op mouse embryo when compared with WT littermates. (b) Down-regulated 
phagocytosis/engulfment-related genes (7 of 13 genes, 54%), (c) smooth muscle contraction-related genes (9 
of 18 genes, 50%), and (d) selected pericyte-related genes (5 of 11 genes, 45%) in the dorsal midline area of the 
Csf1op/op mouse embryo, as compared with a WT littermate. The top 4 down-regulated genes in (d), Kcnj8, Rgs5, 
Dlk1, and Abcc9, have been reported as cerebrovascular pericyte markers in mouse embryo. (e) Expression of 
Kcnj8, Rgs5, Dlk1, and Abcc9 were confirmed by real-time PCR (*P < 0.05; WT = 3; Csf1op/op = 4). All error bars 
indicate the mean ± s.e.m.
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Histology. Embryos were fixed in 4% paraformaldehyde, dehydrated, embedded in paraffin, and sectioned 
with a microtome. Hematoxylin and eosin staining was carried out using a standard procedure. Tissue specimens 
were then observed under a BX51 microscope (Olympus).
Transmission electron microscopy. E10.5 WT embryos were fixed in a solution containing 4% formal-
dehyde and 2.5% glutaraldehyde in 0.1 M sodium phosphate buffer (pH 7.4) for 2 hours at room temperature and 
postfixed in 1% osmium tetroxide in the same buffer solution. The samples were then dehydrated in a graded 
series of ethanol and embedded in Epon 812 resin mixture (TAAB, Berks, UK). Ultra-thin sections approximately 
70 nm thick were cut on an EM UC6 ultramicrotome (Leica Microsystems) and then stained with uranyl acetate 
and lead citrate. The specimens were examined with an H-7500 electron microscope (HITACHI, Tokyo, Japan).
Figure 7. NG2+ cells are absent from the dorsal midline of Ncx1−/− mice and CD31+F4/80+NG2− cells 
fractionated from yolk sac transdifferentiate into NG2+ pericytes in culture models. (a) Immunofluorescence 
of Ncx1−/− mice shows no recruitment of the NG2+ cells (equivalent to the CD31+F4/80+ cells) to the dorsal 
midline (green, arrowheads). While NG2+ pericytes (green) associated with the SVP (red) in WT mice, this 
was not observed in Ncx1−/− mice. Additionally, vascular meshworks appear to be diminished and relatively 
larger blood vessels can be observed. In Ncx1−/− yolk sacs, hematopoiesis (confirmed by TER-119+ embryonic 
erythrocytes) is not substantially diminished. (b and c) CD31+F4/80+NG2− cells fractionated from yolk sacs 
of mCherry+ embryos, which constitutively express nuclear-localized mCherry protein, transdifferentiate 
into NG2+ pericytes. (b) mCherry+CD31+F4/80+NG2− cells (red) are cultured with b.End5 cells and 
neural stem/progenitor cells. On 7DIV, the mCherry+ cells (red, arrowhead) express NG2 (green) and show 
foot processes, a typical structure of mature pericytes. (c) Following 3 days of retinal explant culture with 
mCherry+CD31+F4/80+NG2− cells, the mCherry+ cells (red, arrowhead) express NG2 (green), and enwrap 
retinal blood vessels (cyan). Nuclei are counterstained with Hoechst (blue). Scale bars represent 50 μm (a), 
20 μm (b), and 10 μm (c).
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Cell sorting and cell culture. To prepare CD31+F4/80+ cells from E10.5 mouse brains, WT or Egfp Tg 
brains were mechanically triturated with a pipette in PBS on ice. To fractionate CD31+F4/80+NG2− cells from 
yolk sacs, E10.5 R26-mCherry mouse yolk sacs were digested using Accutase (Nacalai Tesque) with 0.2% colla-
genase (Nacalai Tesque) and 0.005% trypsin inhibitor (Nacalai Tesque) for 1 hour at 37 °C then gently triturated 
with a pipette on ice. These cells were rinsed in PBS and then blocked with 3% normal mouse serum (Dako, 
Glostrup, Denmark) on ice for 10 min. Blocked cells were simultaneously stained with a PE-conjugated anti-F4/80 
antibody (Bio-Rad Laboratories), an APC-conjugated anti-CD31 antibody (BD Biosciences) and, if needed, an 
Alexa488-conjugated anti-NG2 antibody (Merck Millipore) on ice for 15 min. Labeled cells were sorted using a 
FACSAria cell sorter (BD Biosciences). CD31+F4/80+ cells sorted from WT embryonic brains were seeded on 
fibronectin- or collagen type I-coated 8-well slides (BD Biosciences) and cultured in HuMedia-EG (KURABO, 
Osaka, Japan) for the durations indicated. CD31+F4/80+NG2− cells sorted from R26-mCherry mouse yolk sacs 
were co-cultured with b.End5 cells and mouse neural stem/progenitor cells for the durations indicated.
Matrigel plug assay. Matrigel (BD Biosciences), which was interfused with FACSAria-sorted 
EGFP+CD31+F4/80+ cells as described above, was subcutaneously injected into 8-week-old male WT C57BL/6 
mice. After 2 weeks, the plugs were surgically collected, fixed, cut on a CM3000 cryostat (Leica Microsystems), 
and then immunostained as described above. Specimens were observed using a TCS SP5 confocal system (Leica 
Microsystems) and a BX51 fluorescent microscope (Olympus).
Figure 8. Nrp1−/− mice show intact recruitment of hematopoietic-lineage pericytes. (a) Nrp1−/− mice show 
intact recruitment of the NG2+ cells (green, equivalent to the CD31+F4/80+ cells) to the dorsal midline area, 
similar to WT littermates (WT, 4.33 ± 0.67; Nrp1−/−, 5.18 ± 0.75). CD31 staining delineates SVP (red). Nuclei 
are counterstained with Hoechst (blue). Statistical analysis of NG2+ cell recruitment shows no significant 
difference between the 2 genotypes (WT = 5, Nrp1−/− = 4, 200 × 200 μm). Scale bars represent 100 μm. (b) 
Proposed scheme of macrophage-derived pericyte coverage in the SVP. (1) During the very early phase of 
vascular development in the CNS, CD31+F4/80+ cells (hematopoietic-lineage pericyte subset) are transported 
by the blood and infiltrate the dorsal midline area. Concomitant with infiltration in the neuroepithelium, 
CD31+F4/80+ cells express NG2 and adhere to the developing SVP. (2) CD31+F4/80+ cells proliferate, migrate 
along the capillaries, and transdifferentiate into mature pericytes. (3) Pericyte coverage of the SVP is completed.
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Embryonic explant culture. FACSAria-sorted EGFP+CD31+F4/80+ cells, as described above, were intrac-
erebroventricularly injected into age-matched E10.5 WT embryos. The embryos were then explant-cultured for 
2 days using an EGM-2 BulletKit (Lonza, Allendale, NJ). The explant-cultured embryos were harvested, fixed, 
and the brains were excised for immunostaining as described above. The immunostained whole-mount speci-
mens were observed using a TCS SP5 confocal system (Leica Microsystems) and a BX51 fluorescent microscope 
(Olympus).
Retinal explant culture. FACSAria-sorted mCherry+CD31+F4/80+NG2− cells were seeded onto 
flat-sheeted WT mouse retinas in an explant culture system63. The retinas were explant-cultured for 3 days using 
NeuroCult (STEMCELL Technologies, Vancouver, Canada) supplemented with 20 ng/ml FGF2 (PeproTech, 
Rocky Hill, NJ), 20 ng/ml EGF (PeproTech), and 2% FBS (Sigma-Aldrich). The explant-cultured retinas were 
fixed and immunostained as described above. The immunostained whole-mount retinas were observed using a 
TCS SP5 confocal system (Leica Microsystems).
Single-cell-tracing time-lapse analysis. For single-cell-tracing time-lapse, EGFP+ phagocytes (see 
Figures 1 and 3, and Supplementary Figure 2) were manually isolated from the dorsal midline area of E10.5 
Egfp Tg mouse embryos. PKH26-stained (Sigma-Aldrich) b.End5 cells were used as scaffold cells. Cells were 
maintained in a microscope stage incubator at 37 °C in a humidified atmosphere containing 5% CO2 throughout 
the experiment. Z-stack confocal images were collected in 10-minute intervals using a TCS SP5 confocal system 
(Leica Microsystems). Projection images and movies were obtained using LAS AF software (Leica Microsystems).
RNA extraction, cDNA synthesis, and real-time PCR. Total RNA was isolated from E10.5 mouse dor-
sal midline areas using the RNeasy Mini Kit (Qiagen) according to the manufacturer’s instructions. Total RNA (1 
μg) was reverse-transcribed as detailed in the PrimeScript RT reagent Kit protocol (Takara). For real-time PCR 
performed with an Mx3000 P (Agilent Technologies), cDNA was diluted 1:20 and PCR was performed using 
SYBR Premix EX Taq II (Takara). The real-time PCR program consisted of hot start enzyme activation at 95 °C 
for 10 sec followed by 40 cycles of amplification at 95 °C for 10 sec and 60 °C for 40 sec, as previously reported64, 65. 
Finally, to obtain the dissociation curve, a final cycle was performed at 95 °C for 1 min, 60 °C for 30 sec, and 
then 95 °C for 10 sec. For the data analysis, mouse glyceraldehyde-3-phosphate dehydrogenase (Gapdh) or β-actin 
(Actb) was used as an internal control. Induction values were calculated using MxPro analysis software (Agilent 
Technologies). Primer sequences are available upon request from the TAKARA BIO INC. website (http://www.
takara-bio.co.jp).
Gene expression microarray. Quantitative analysis of RNA expression was performed using Affymetrix 
gene chip cDNA microarrays (Affymetrix, Santa Clara, CA) according to the manufacturer’s protocol. Total RNA 
was prepared from E10.5 dorsal midline areas using the RNeasy Mini Kit (Qiagen, Hilden, Germany). RNA qual-
ity was measured using an Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA) to ensure the integ-
rity of the RNA. Synthesis of cDNA, hybridization to the Affymetrix GeneChip Mouse Genome 430 2.0 Array 
(over 39,000 transcripts), and analysis were performed using a GeneChip 3000 Scanner (Affymetrix) accord-
ing to standard protocols. The complete microarray data sets are available from the Gene Expression Omnibus 
(GSE46800).
Statistical analysis. Statistical significance was determined using the Student’s t test. P values of <0.05 were 
considered statistically significant. Graphs were drawn using GraphPad Prism 6 (GraphPad Software, Inc., La 
Jolla, CA). Quantified data are presented as mean ± s.e.m. Each experiment was performed at least 3 times with 
similar results. Immunofluorescence studies were performed at least twice with independent staining experi-
ments, and samples were prepared from at least 3 pregnant animals. However, only 2 individual Ncx1−/− concep-
tuses were utilized, prepared from 2 pregnant females.
References
 1. Armulik, A., Abramsson, A. & Betsholtz, C. Endothelial/pericyte interactions. Circ Res 97, 512–523 (2005).
 2. Fujiwara, T., Tenkova, T. I. & Kondo, M. Wall cytoarchitecture of the rat ciliary process microvasculature revealed with scanning 
electron microscopy. Anat Rec 254, 261–268 (1999).
 3. Baluk, P., Hashizume, H. & McDonald, D. M. Cellular abnormalities of blood vessels as targets in cancer. Curr Opin Genet Dev 15, 
102–111 (2005).
 4. Peppiatt, C. M., Howarth, C., Mobbs, P. & Attwell, D. Bidirectional control of CNS capillary diameter by pericytes. Nature 443, 
700–704 (2006).
 5. Hall, C. N. et al. Capillary pericytes regulate cerebral blood flow in health and disease. Nature 508, 55–60 (2014).
 6. Armulik, A. et al. Pericytes regulate the blood-brain barrier. Nature 468, 557–561 (2010).
 7. Daneman, R., Zhou, L., Kebede, A. A. & Barres, B. A. Pericytes are required for blood-brain barrier integrity during embryogenesis. 
Nature 468, 562–566 (2010).
 8. Bell, R. D. et al. Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging. 
Neuron 68, 409–427 (2010).
 9. Lindahl, P., Johansson, B. R., Leveen, P. & Betsholtz, C. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. 
Science 277, 242–245 (1997).
 10. Hellstrom, M. et al. Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis. J Cell Biol 153, 
543–553 (2001).
 11. Shen, J. et al. PDGFR-beta as a positive regulator of tissue repair in a mouse model of focal cerebral ischemia. J Cereb Blood Flow 
Metab 32, 353–367 (2012).
 12. Fantin, A. et al. Tissue macrophages act as cellular chaperones for vascular anastomosis downstream of VEGF-mediated endothelial 
tip cell induction. Blood 116, 829–840 (2010).
 13. Stefater, J. A. 3rd et al. Regulation of angiogenesis by a non-canonical Wnt-Flt1 pathway in myeloid cells. Nature 474, 511–515 
(2011).
www.nature.com/scientificreports/
1 5Scientific RepoRts | 7: 3855  | DOI:10.1038/s41598-017-03994-1
 14. Moore, K. J. & Tabas, I. Macrophages in the pathogenesis of atherosclerosis. Cell 145, 341–355 (2011).
 15. Maruyama, K. et al. Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages. J Clin Invest 
115, 2363–2372 (2005).
 16. Kerjaschki, D. et al. Lymphatic endothelial progenitor cells contribute to de novo lymphangiogenesis in human renal transplants. 
Nat Med 12, 230–234 (2006).
 17. Rucker, H. K., Wynder, H. J. & Thomas, W. E. Cellular mechanisms of CNS pericytes. Brain Res Bull 51, 363–369 (2000).
 18. Hungerford, J. E. & Little, C. D. Developmental biology of the vascular smooth muscle cell: building a multilayered vessel wall. J Vasc 
Res 36, 2–27 (1999).
 19. Heglind, M. et al. Lack of the central nervous system- and neural crest-expressed forkhead gene Foxs1 affects motor function and 
body weight. Mol Cell Biol 25, 5616–5625 (2005).
 20. Korn, J., Christ, B. & Kurz, H. Neuroectodermal origin of brain pericytes and vascular smooth muscle cells. J Comp Neurol 442, 
78–88 (2002).
 21. Etchevers, H. C., Vincent, C., Le Douarin, N. M. & Couly, G. F. The cephalic neural crest provides pericytes and smooth muscle cells 
to all blood vessels of the face and forebrain. Development 128, 1059–1068 (2001).
 22. Yamanishi, E., Takahashi, M., Saga, Y. & Osumi, N. Penetration and differentiation of cephalic neural crest-derived cells in the 
developing mouse telencephalon. Dev Growth Differ 54, 785–800 (2012).
 23. Ruhrberg, C. et al. Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching 
morphogenesis. Genes Dev 16, 2684–2698 (2002).
 24. Bertrand, J. Y. et al. Three pathways to mature macrophages in the early mouse yolk sac. Blood 106, 3004–3011 (2005).
 25. Nagata, S. Apoptosis and autoimmune diseases. Ann N Y Acad Sci 1209, 10–16 (2010).
 26. Geissmann, F. et al. Development of monocytes, macrophages, and dendritic cells. Science 327, 656–661 (2010).
 27. Armulik, A., Genove, G. & Betsholtz, C. Pericytes: developmental, physiological, and pathological perspectives, problems, and 
promises. Dev Cell 21, 193–215 (2011).
 28. Ikawa, M., Yamada, S., Nakanishi, T. & Okabe, M. Green fluorescent protein (GFP) as a vital marker in mammals. Curr Top Dev Biol 
44, 1–20 (1999).
 29. Klappacher, G. W. et al. An induced Ets repressor complex regulates growth arrest during terminal macrophage differentiation. Cell 
109, 169–180 (2002).
 30. Aziz, A., Soucie, E., Sarrazin, S. & Sieweke, M. H. MafB/c-Maf deficiency enables self-renewal of differentiated functional 
macrophages. Science 326, 867–871 (2009).
 31. de Boer, J. et al. Transgenic mice with hematopoietic and lymphoid specific expression of Cre. Eur J Immunol 33, 314–325 (2003).
 32. Srinivas, S. et al. Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus. BMC Dev Biol 1, 4 
(2001).
 33. Niida, S. et al. VEGF receptor 1 signaling is essential for osteoclast development and bone marrow formation in colony-stimulating 
factor 1-deficient mice. Proc Natl Acad Sci USA 102, 14016–14021 (2005).
 34. Yoshida, H. et al. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. 
Nature 345, 442–444 (1990).
 35. Shinkai, Y. et al. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 68, 855–867 
(1992).
 36. Lux, C. T. et al. All primitive and definitive hematopoietic progenitor cells emerging before E10 in the mouse embryo are products 
of the yolk sac. Blood 111, 3435–3438 (2008).
 37. Koushik, S. V. et al. Targeted inactivation of the sodium-calcium exchanger (Ncx1) results in the lack of a heartbeat and abnormal 
myofibrillar organization. FASEB J 15, 1209–1211 (2001).
 38. Kawasaki, T. et al. A requirement for neuropilin-1 in embryonic vessel formation. Development 126, 4895–4902 (1999).
 39. Sato, H. et al. PDGFR-beta Plays a Key Role in the Ectopic Migration of Neuroblasts in Cerebral Stroke. Stem Cells (2015).
 40. Maes, C. et al. Osteoblast precursors, but not mature osteoblasts, move into developing and fractured bones along with invading 
blood vessels. Dev Cell 19, 329–344 (2010).
 41. Kojima, T. et al. Subventricular zone-derived neural progenitor cells migrate along a blood vessel scaffold toward the post-stroke 
striatum. Stem Cells 28, 545–554 (2010).
 42. Wynn, T. A., Chawla, A. & Pollard, J. W. Macrophage biology in development, homeostasis and disease. Nature 496, 445–455 (2013).
 43. Fujimoto, K. Pericyte-endothelial gap junctions in developing rat cerebral capillaries: a fine structural study. Anat Rec 242, 562–565 
(1995).
 44. Kamouchi, M., Ago, T., Kuroda, J. & Kitazono, T. The possible roles of brain pericytes in brain ischemia and stroke. Cell Mol 
Neurobiol 32, 159–165 (2012).
 45. Ando, K. et al. Clarification of mural cell coverage of vascular endothelial cells by live imaging of zebrafish. Development 143, 
1328–1339 (2016).
 46. Foster, K. et al. Contribution of neural crest-derived cells in the embryonic and adult thymus. J Immunol 180, 3183–3189 (2008).
 47. Muller, S. M. et al. Neural crest origin of perivascular mesenchyme in the adult thymus. J Immunol 180, 5344–5351 (2008).
 48. Rajantie, I. et al. Adult bone marrow-derived cells recruited during angiogenesis comprise precursors for periendothelial vascular 
mural cells. Blood 104, 2084–2086 (2004).
 49. Gaengel, K., Genove, G., Armulik, A. & Betsholtz, C. Endothelial-mural cell signaling in vascular development and angiogenesis. 
Arterioscler Thromb Vasc Biol 29, 630–638 (2009).
 50. Ejaz, S., Chekarova, I., Ejaz, A., Sohail, A. & Lim, C. W. Importance of pericytes and mechanisms of pericyte loss during diabetes 
retinopathy. Diabetes Obes Metab 10, 53–63 (2008).
 51. Cao, R. et al. VEGFR1-mediated pericyte ablation links VEGF and PlGF to cancer-associated retinopathy. Proc Natl Acad Sci USA 
107, 856–861 (2010).
 52. Hirschi, K. K. & D’Amore, P. A. Pericytes in the microvasculature. Cardiovasc Res 32, 687–698 (1996).
 53. Kumar, A. H. & Caplice, N. M. Clinical potential of adult vascular progenitor cells. Arterioscler Thromb Vasc Biol 30, 1080–1087 
(2010).
 54. Germani, A., Di Campli, C., Pompilio, G., Biglioli, P. & Capogrossi, M. C. Regenerative therapy in peripheral artery disease. 
Cardiovasc Ther 27, 289–304 (2009).
 55. Nakamura, T. & Mizuno, S. The discovery of hepatocyte growth factor (HGF) and its significance for cell biology, life sciences and 
clinical medicine. Proc Jpn Acad Ser B Phys Biol Sci 86, 588–610 (2010).
 56. Raza, A., Franklin, M. J. & Dudek, A. Z. Pericytes and vessel maturation during tumor angiogenesis and metastasis. Am J Hematol 
85, 593–598 (2010).
 57. Muramatsu, M., Yamamoto, S., Osawa, T. & Shibuya, M. Vascular endothelial growth factor receptor-1 signaling promotes 
mobilization of macrophage lineage cells from bone marrow and stimulates solid tumor growth. Cancer Res 70, 8211–8221 (2010).
 58. Hiratsuka, S., Minowa, O., Kuno, J., Noda, T. & Shibuya, M. Flt-1 lacking the tyrosine kinase domain is sufficient for normal 
development and angiogenesis in mice. Proc Natl Acad Sci USA 95, 9349–9354 (1998).
 59. Kano, M. R. et al. Improvement of cancer-targeting therapy, using nanocarriers for intractable solid tumors by inhibition of TGF-
beta signaling. Proc Natl Acad Sci USA 104, 3460–3465 (2007).
 60. Abe, T. et al. Establishment of conditional reporter mouse lines at ROSA26 locus for live cell imaging. Genesis 49, 579–590 (2011).
www.nature.com/scientificreports/
1 6Scientific RepoRts | 7: 3855  | DOI:10.1038/s41598-017-03994-1
 61. Yamamoto, S. et al. Inflammation-induced endothelial cell-derived extracellular vesicles modulate the cellular status of pericytes. Sci 
Rep 5, 8505 (2015).
 62. Yamamoto, S. et al. Essential role of Shp2-binding sites on FRS2alpha for corticogenesis and for FGF2-dependent proliferation of 
neural progenitor cells. Proc Natl Acad Sci USA 102, 15983–15988 (2005).
 63. Moritoh, S., Tanaka, K. F., Jouhou, H., Ikenaka, K. & Koizumi, A. Organotypic tissue culture of adult rodent retina followed by 
particle-mediated acute gene transfer in vitro. PLoS One 5, e12917 (2010).
 64. Horikawa, S. et al. PDGFRalpha plays a crucial role in connective tissue remodeling. Sci Rep 5, 17948 (2015).
 65. Sato, H. et al. PDGFR-beta Plays a Key Role in the Ectopic Migration of Neuroblasts in Cerebral Stroke. Stem Cells 34, 685–698 
(2016).
Acknowledgements
We thank the members of the Department of Pathology at the University of Toyama for helpful discussions. 
We also thank Y. Watanabe for cell sorting, H. Kato and S. Kuwahara for technical support for the confocal 
microscopic analysis, and N. Yamamoto, A. Yamamoto and R. Yamamoto for broad-based support. This work 
was supported by a Grant-in-Aid for Scientific Research on Innovative Areas (JP23122506; to S.Y.) and Grant-in-
Aid for Scientific Research (JP26460360; to S.Y.) from The Ministry of Education, Culture, Sports, Science and 
Technology, and Ishidsu Shun Memorial Scholarship.
Author Contributions
S.Y. conceived and designed the project. S.Y., M.M., E.A., M.I., Y.N., H.S., B-N.K., S.K., E.O.D. and M. Sugimori 
performed experiments. S.Y. wrote the manuscript with significant input from M.M., M. Sugimori, T.O., H.T., 
K.T., M.D., I.U., Y.W., N.H., T.I., I.K., K.Takatsu, K.Tobe, S.N., N.M., M. Shibuya and M. Sasahara.
Additional Information
Supplementary information accompanies this paper at doi:10.1038/s41598-017-03994-1
Competing Interests: The authors declare that they have no competing interests.
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and 
institutional affiliations.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International 
License, which permits use, sharing, adaptation, distribution and reproduction in any medium or 
format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Cre-
ative Commons license, and indicate if changes were made. The images or other third party material in this 
article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the 
material. If material is not included in the article’s Creative Commons license and your intended use is not per-
mitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the 
copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
 
© The Author(s) 2017
